Evidence map›Paper›PMID 36479093›Full record

ArticleFrontiers in medicine2022

Do worsening lung ultrasound scans identify severe COVID-19 trajectories?

Paul W Blair, Jimin Hwang, Jackson Pearce, Tiffany C Fong, Erjia Cui, Phabiola Herrera, Gigi Liu, Ciprian Crainiceanu, Trishul Siddharthan, Danielle V Clark and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Paul W BlairHenry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States.
Jimin HwangDepartment of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Jackson PearceCollege of Medicine, Medical University of South Carolina, Charleston, SC, United States.
Tiffany C FongDepartment of Emergency Medicine, Johns Hopkins University, Baltimore, MD, United States.
Erjia CuiDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Phabiola HerreraDivision of Pulmonary and Critical Care Medicine, University of Miami, Miami, FL, United States.
Gigi LiuDivision of General Internal Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Ciprian CrainiceanuDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Trishul SiddharthanDivision of Pulmonary and Critical Care Medicine, University of Miami, Miami, FL, United States.
Danielle V ClarkHenry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States.
CCPSEI Research Team
Johns Hopkins University · USHenry M. Jackson Foundation · USUniversity of Miami · USJohns Hopkins Medicine · USMedical University of South Carolina · USThe University of Texas Southwestern Medical Center · US

Funding

Effectiveness of Low-dose Theophylline for the Management of Biomass-associated COPD in PeruK23HL146946 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SIDDHARTHAN, TRISHUL · 2019 to 2023
$985k
NHLBI NIH HHS K23 HL146946
6 · The paper itself

Abstract

Background: While point-of-care ultrasound (POCUS) has been used to track worsening COVID-19 disease it is unclear if there are dynamic differences between severity trajectories. Methods: We studied 12-lung zone protocol scans from 244 participants [with repeat scans obtained in 3 days ( Results: Mean LUS scores were elevated by 0.19 ( Discussion: Our results do not support the use of serial LUS scans to monitor COVID-19 disease progression among hospitalized adults.

Indexed as

cohort studyCOVID-19lung ultrasoundpoint-of-care lung ultrasoundsevere COVID-19

Identifiers

PMID36479093
PMCPMC9720255
OpenAlexW4309738109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.